Pyxis Oncology, Inc. Quarterly Debt-to-equity in % from Q2 2022 to Q3 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Pyxis Oncology, Inc. quarterly Debt-to-equity history and growth rate from Q2 2022 to Q3 2024.
Pyxis Oncology, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 25.9 %, a 3.24% decline year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q3 2024	25.9	-0.87	-3.24%	Sep 30, 2024
Q2 2024	27.8	+5.15	+22.8%	Jun 30, 2024
Q1 2024	27.5	+6.86	+33.3%	Mar 31, 2024
Q4 2023	28.1	+11	+64.5%	Dec 31, 2023
Q3 2023	26.8	+15.3	+132%	Sep 30, 2023
Q2 2023	22.6	+9.17	+68.2%	Jun 30, 2023
Q1 2023	20.6			Mar 31, 2023
Q4 2022	17			Dec 31, 2022
Q3 2022	11.6			Sep 30, 2022
Q2 2022	13.4			Jun 30, 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.